References
Roy D, Talajic M, Nattel S et al (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667–2677
Vanassche T, Lauw MN, Eikelboom JW et al (2015) Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. Eur Heart J 36:281–287
Rienstra M, Hobbelt AH, Alings M et al (2018) Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. Eur Heart J 39:2987–2996
Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 18:1609–1678
Weijs B, Pisters R, Haest RJ et al (2012) Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls. Heart Rhythm 9:1923–1929
Hobbelt AH, Spronk HM, Crijns HJGM, Ten Cate H, Rienstra M, Van Gelder IC (2017) Prethrombotic state in young very low-risk patients with atrial fibrillation. J Am Coll Cardiol 69:1990–1992
Spronk HM, De Jong AM, Verheule S et al (2016) Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation. Eur Heart J 38:38–50
Echouffo-Tcheugui JB, Shrader P, Thomas L et al (2017) Care patterns and outcomes in atrial fibrillation patients with and without diabetes: ORBIT-AF registry. J Am Coll Cardiol 70:1325–1335
Fatemi O, Yuriditsky E, Tsioufis C et al (2014) Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the action to control cardiovascular risk in diabetes study). Am J Cardiol 114:1217–1222
Wang A, Green JB, Halperin JL, Piccini JP (2019) Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2019.07.020
Funding
The study is supported by the Netherlands Heart Foundation (Grant 2008B035). Unrestricted grants from AstraZeneca, Bayer, Biotronik, Boehringer-Ingelheim, Boston Scientific, Medtronic, Sanofi-Aventis, St. Jude Medical paid to the Netherlands Heart Institute. The authors have nothing to disclose.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Trial Registration number: Clinicaltrials.gov NCT00877643.
Rights and permissions
About this article
Cite this article
de With, R.R., Rienstra, M., Crijns, H.J.G.M. et al. Determinants of sinus rhythm maintenance in patients with early-persistent atrial fibrillation and heart failure. Clin Res Cardiol 109, 787–789 (2020). https://doi.org/10.1007/s00392-019-01581-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-019-01581-0